GSK3B and Parkinson disease: Both GSK-3β and mTOR regulate numerous IGF-IRβ-dependent processes that become impaired in the course of Parkinson’s disease—including apoptosis, autophagy, neuronal metabolism, protein synthesis, and synaptic plasticity (Figure 3) [122].